Global Short Read Sequencing Market Analysis 2025–2029: Opportunities for Strategic Growth
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Short Read Sequencing Market Size Likely To Evolve From 2025 Through 2034?
The short read sequencing sector has experienced a swift expansion lately, projecting an increase from its 2024 valuation of $6.66 billion to $7.8 billion by 2025, reflecting a consistent annual growth rate of 17.2%. This upward trajectory observed during the historical timeframe is primarily due to several contributing factors, including heightened efforts in genomic research, a rising incidence of hereditary conditions, ongoing advancements in pharmaceutical and biotechnology studies, wider adoption in diagnostic uses, and the progressive reduction in the expense associated with sequencing technologies.
The short read sequencing market is projected for substantial expansion over coming years, reaching a valuation of $15.06 billion by 2029, driven by a compound annual growth rate (CAGR) of 17.9%; this forward trajectory is fueled by progress in precision medicine, the escalating development of personalized genomics, broader utilization within agriculture, increased investigation into the microbiome, and mounting requirements in nascent economies, while key developments defining this era will encompass greater automation and high-volume processing, the adoption of cloud-centric platforms, the incorporation of artificial intelligence and machine learning methodologies, the emergence of sequencing devices that are more portable, and cooperative advancements with long-read sequencing techniques.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11912&type=smp
Which Drivers Are Impacting The Short Read Sequencing Market?
The increasing incidence of hereditary ailments serves as a key catalyst anticipated to boost the expansion of the short-read sequencing industry moving ahead. Abnormalities or alterations within a person’s genetic makeup, which result in physical, developmental, or biochemical irregularities affecting health constitute these genetic conditions. In examining the genome and thoroughly pinpointing variations linked to illness, short-read sequencing finds application within the sphere of genetic diseases. To illustrate this demand mechanism, data released by RARE-X, an Australian platform dedicated to patient support, indicated in June 2022 that there were 10,867 rare diseases cataloged, spanning both genetic and non-genetic origins. Consequently, the growing frequency of genetic disorders is directly fueling the market expansion for short-read sequencing technologies.
What Are The Major Segment Categories Driving The Short Read Sequencing Market Growth?
The short read sequencingmarket covered in this report is segmented –
1) By Product: Instruments, Consumables, Services.
2) By Technology: Next-Generation Sequencing, Sanger Sequencing.
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis.
4) By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri genomics And Forensics, HLA Typing Or Immune System Monitoring.
5) By End Users: Academic Research, Hospitals And Clinics, Clinical Research, Pharmaceutical And Biotechnology Companies.
Subsegments:
1) By Instruments: Next-Generation Sequencing (NGS) Systems, Sequencing Platforms, Library Preparation Systems
2) By Consumables: Reagents And Kits, Flow Cells, Sample Preparation Consumables
3) By Services: Sequencing Services, Data Analysis Services, Bioinformatics Services
What Are The Latest Industry Trends Transforming The Short Read Sequencing Market?
Progress in technology represents the primary trend increasingly favored within the short-read sequencing sector. Core industry players operating in this segment are concentrating efforts on technological evolution as a means to enhance their analytical capabilities and maintain competitive standing. As an illustration, during October 2022, Pacific Biosciences Inc., an American developer renowned for superior, high-fidelity sequencing instrumentation, initiated external beta evaluations for its Onso sequencing system. This particular apparatus was engineered to yield highly accurate data coupled with favorable economics. Furthermore, this specific short-read platform was created with the intent of delivering rigorous and focused sequence analysis outcomes to experts specializing in oncology research.
Who Are The Primary Competitors In The Global Short Read Sequencing Market?
Major companies operating in the short read sequencing market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Cytiva Lifesciences, Eurofins Scientific SE, Agilent Technologies Inc., Beckman Coulter Inc., Illumina Inc., QIAGEN N.V., PerkinElmer Inc., BGI Genomics Co Ltd, MGI Tech Co. Ltd., GenScript Biotech Corporation., 10x Genomics Inc., Novogene Co. Ltd, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., Genewiz Inc., Zymo Research Corporation, GenapSys Inc., Fasteris SA, Paragon Genomics Inc., Nabsys Inc., GATC Biotech AG
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report
What Are The Regional Market Dynamics Impacting The Short Read Sequencing Industry?
North America was the largest region in the Short Read Sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Short Read Sequencing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=11912&type=smp
Browse Through More Reports Similar to the Global Short Read Sequencing Market 2025, By The Business Research Company
Rna Analysis Transcriptomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
Antisense And Rnai Therapeutics Global Market Report 2025
Next Generation Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
